Systematic review shows increased risk of retinopathy in patients on hydroxychloroquine, indicating need for careful monitoring.
HCQ-R risk increases with duration and is dose-dependent, reaching 5.6% by 15 years. Findings support dose optimization with intensified screening for higher-risk patients including CKD, female and Asian patients.
No takes yet. Share an insight, caveat, or question.
Tiraihi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: